COVID-19 Testing in Patients With Vascular Disorders

Medical University of Vienna

Status: Completed

Conditions: Covid19

Treatments: Diagnostic Test: PCR

Study type: Observational

Funder types: Other

Identifiers

NCT04838093

2049/2020

Details and patient eligibility

About

Background: To investigate the prevalence of SARS-CoV-2 infection in hospitalized patients with vascular disorders after implementing institutional and governmental safety measures.

Materials and Methods: Vascular patients (VPs) admitted to our tertiary care hospital were routinely tested for SARS-CoV-2 infection on a two days basis between March and December, 2020. The prevalence of SARS-CoV-2 was compared between VPs and two independent Austrian populations (April and November 2020) tested by the Austrian Ministry of Science. The results were also compared to a cohort of health care personnel (HCP) working in close proximity to the study patients, tested weekly, between March and December, 2020. RT-PCR and antigen test were used to detect SARS-CoV-2.

Enrollment: 2,243 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

All inpatient admissions

Exclusion criteria

Outpatient admissions

Trial design

2,243 participants in 3 patient groups

Patient cohort:

Description:

all patients with vascular disorders consecutively admitted at our tertiary care hospital from March 16 to December 07, 2020

Treatment:

Diagnostic Test: PCR

Control cohort:

Description:

data of two nationwide PCR-based studies conducted in a representative random sample, from April 1-6, and November 12-14, 2020, collected by the Austrian Ministry of Science and the Austrian Red Cross to estimate the spread of SARS-CoV-2 infection among the non-hospitalized Austrian population.

Treatment:

Diagnostic Test: PCR

HCP cohort:

Description:

HCP worker data, including nurses, nurse technicians, physicians, surgical personal, physical therapists, nurse practitioners, environmental service workers, administrative staff, and dietitians, working in close proximity to admitted patients at our tertiary care hospital from March 16 to December 07, 2020.

Treatment:

Diagnostic Test: PCR